Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 4

Conditions

Carcinoma, Non-Small-Cell Lung 64Lung Neoplasms 27Triple Negative Breast Neoplasms 19Squamous Cell Carcinoma of Head and Neck 16Breast Neoplasms 16Small Cell Lung Carcinoma 12Parkinson Disease 4, Autosomal Dominant Lewy Body 12Ovarian Neoplasms 12Fallopian Tube Neoplasms 12Endometrial Neoplasms 11Neoplasms 9Neoplasm Metastasis 6Carcinoma 6Oropharyngeal Neoplasms 5Urinary Bladder Neoplasms 4Mouth Neoplasms 4Lung Diseases 4Laryngeal Neoplasms 4Head and Neck Neoplasms 4Colorectal Neoplasms 4Adenocarcinoma of Lung 4Uterine Cervical Neoplasms 3Respiratory Tract Neoplasms 3Prostatic Neoplasms 3Mesothelioma 3Hypopharyngeal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Central Nervous System Neoplasms 3Carcinoma, Ovarian Epithelial 3Advanced Solid Tumors 3

Interventions

pembrolizumab 14Cisplatin 8Carboplatin 4dostarlimab 3Cetuximab 3abemaciclib 2Surgical Procedures, Operative 2Radiotherapy, Intensity-Modulated 2Paclitaxel 2Nivolumab 2Fulvestrant 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2tislelizumab 1ribociclib 1repotrectinib 1patritumab deruxtecan 1palbociclib 1osimertinib 1olaparib 1niraparib 1nimotuzumab 1merphos 1ibrutinib 1fludarabine 1exemestane 1entrectinib 1carbohydrate-deficient transferrin 1brodalumab 1avelumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Head and Neck Neoplasms × Carboplatin × 30 days × Clear all
NCT04858269 2026-05-22

First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients

Wake Forest University Health Sciences

Phase 2 Active not recruiting
32 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT07601737 2026-05-22

Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2 Recruiting
182 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT05420948 2026-05-12

A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer

University of Chicago

Phase 2 Recruiting
30 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT02270814 2026-05-05

CACTUX

Washington University School of Medicine

Phase 2 Active not recruiting
74 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡